- $25.22bn
- $23.94bn
- $2.17bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 675 | 883 | 1,301 | 1,731 | 2,170 |
Cost of Revenue | |||||
Gross Profit | 545 | 716 | 1,042 | 1,417 | 1,825 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 722 | 944 | 1,360 | 1,846 | 2,374 |
Operating Profit | -47 | -61.3 | -59.7 | -115 | -204 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -50.8 | -80.8 | -73.8 | -105 | -158 |
Provision for Income Taxes | |||||
Net Income After Taxes | -53.7 | -85 | -77.8 | -113 | -176 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -53.7 | -85 | -77.8 | -113 | -176 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -53.7 | -85 | -77.8 | -113 | -176 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.27 | -1.74 | -1.58 | -2.27 | -2.33 |